Platelet hemostasis in patients with metabolic syndrome and type 2 diabetes mellitus: cGMP- and NO-dependent mechanisms in the insulin-mediated platelet aggregation

Patients with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) have high risk of microcirculation complications and microangiopathies. An increase in thrombogenic risk is associated with platelet hyperaggregation, hypercoagulation, and hyperfibrinolysis. Factors leading to platelet acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Suslova, Tatiana E., Sitozhevskii, Alexei V., Ogurkova, Oksana N., Kravchenko, Elena S., Kologrivova, Irina V., Anfinogenova, Yana, Karpov, Rostislav S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283519/
https://www.ncbi.nlm.nih.gov/pubmed/25601838
http://dx.doi.org/10.3389/fphys.2014.00501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283519/
https://www.ncbi.nlm.nih.gov/pubmed/25601838
http://dx.doi.org/10.3389/fphys.2014.00501

Ejemplares similares